Joseph Romanelli - 29 Apr 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: President, Human Health Int?l
Signature: /s/ Kelly E. W. Grez, attorney-in-fact for Joseph Romanelli
Issuer symbol: MRK
Transactions as of: 29 Apr 2025
Net transactions value: $0
Form type: 4
Filing time: 01 May 2025, 17:43:06 UTC
Previous filing: 06 Jan 2025
Next filing: 02 May 2025
SEC: View on sec.gov

This filing has been restated, see here for the amended filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MRK	Common Stock						21,799	29 Apr 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Restricted Stock Unit	Award	$0	+4,722		$0.000000	4,722	29 Apr 2025	Common Stock	4,722		Direct	F2, F3
transaction	MRK	Restricted Stock Unit	Award	$0	+9,444		$0.000000	9,444	29 Apr 2025	Common Stock	9,444		Direct	F2, F3
transaction	MRK	Stock Option (Right to Buy)	Award	$0	+21,494		$0.000000	21,494	29 Apr 2025	Common Stock	21,494	$84.71	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Holdings include shares acquired in dividend reinvestment transactions.
F2	Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
F4	The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.